Amanozine
- Level
- Commodity
- Parent
- 51191500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51191529This classification denotes a diuretic with the molecular formula C9H9N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X43W7JDA8L, chemically known as 1,3,5-triazine-2,4-diamine, n-phenyl-, monohydrochloride but generally known as amanozine, which bears US NIH Compound Identifier 10832. Amanozine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amanozine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05388MIG. The term AMANOZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). AMANOZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amanozine under HS 29336980 and SITC 51576. As of Q4 2014, AMANOZINE remains the US FDA Preferred Term for this commodity. Amanozine bears US NLM identifiers UMLS ID C2698079 and NCI Concept Code C74253. SMILES: N(C1CCCCC1)C1NC(NCN1)N.
Same parent
Under 51191500 · 77Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.